Deniz Gökbuget
banner
denizgoekbuget.bsky.social
Deniz Gökbuget
@denizgoekbuget.bsky.social
1.6K followers 340 following 24 posts
Principal Scientist @Genentech | Translational research & biomarker development in prostate cancer. Passionate about bridging science and patient impact.
Posts Media Videos Starter Packs
I’m excited to share that I’ve joined Genentech as a Principal Scientist in Translational Medicine, where I’ll focus on biomarker development and translational research in prostate cancer. I’m looking forward to working with incredible colleagues to advance innovative therapies for patients.
Check out our new BioRepli-seq technique in this invited article related to our recent KMT2C/KMT2D replication timing study ⬇️. We use click chemistry–based biotinylation and on-bead library prep to comprehensively profile genome-wide DNA replication timing.
🔗 star-protocols.cell.com/protocols/4439
Reposted by Deniz Gökbuget
Summary Table of the massive defunding of biomedical research in the United States
www.nytimes.com/interactive/...
Reposted by Deniz Gökbuget
Dr. Cooperberg receives ASPI’s 2025 Special Award for Patient Advocacy for leading a successful campaign to restore Active Surveillance in prostate cancer guidelines. youtu.be/ZHQIkIze6k8?...

Check out his presentation on "Active Surveillance: Past, Present, and Future":
youtu.be/ev1WcQ1Ucic?...
Active Surveillance: Past, Present, and Future
YouTube video by ASPI: Active Surveillance Patients International
youtu.be
Really cool work led by @huaigengxu.bsky.social. Too bad, I don't get to see it live. 🤞
Reposted by Deniz Gökbuget
Dress to kill. Come to see how I created a novel cancer vaccine by transferring MHC-peptide complexes from tumor cells to universal iPSC-derived Dendritic cells.
#ISSCR2025
AI and Cancer Evolution Session, Friday 8:30am, Convention Hall B, level 1
@ucsfcancer.bsky.social
@ucsfstemcell.bsky.social
Reposted by Deniz Gökbuget
great start to ISSCR annual meeting. great session on immune engineering this morning @isscr.org #isscr2025
Reposted by Deniz Gökbuget
We just got an email that Hopkins is freezing salaries, hiring, and some construction projects. In addition to the 800 million USAID we lost, we’ve had another 50 million in grants canceled so far. And a 2/3 year over year decline in funded grants despite an increase in submissions
Reposted by Deniz Gökbuget
Oof, just got notice HHMI is not even doing Hanna Gray Fellows, or any competition, this year due to the challenging times in science funding rn 😬 Understandable. On the bright side, I was really proud my application🌈 #science #nih #hhmi
Reposted by Deniz Gökbuget
A tour de force study from Taipale&Yin labs. It expands the vocabulary of the Regulatory Code by adding 1131 TF:TF composite motifs that are different from the individual TF motifs. The new composite motifs are enriched in cell-type specific elements and active in vivo
www.nature.com/articles/s41...
DNA-guided transcription factor interactions extend human gene regulatory code - Nature
A large-scale analysis of DNA-bound transcription factors (TFs) shows how the presence of DNA markedly affects the landscape of TF interactions, and identifies composite motifs that are recognized by ...
www.nature.com
For decades, NIH funding has fueled breakthroughs in cancer, heart disease and more. But a new policy puts progress at risk. We need Congress to oppose this abrupt change. Join me in emailing lawmakers today! #SaveNIHresearch bit.ly/4hxmfsK
Protect research funding
Federal funding for biomedical research is under threat.
bit.ly
Reposted by Deniz Gökbuget
Trump & Musk are making massive cuts to the National Institutes of Health.

I know there is a lot going on right now, but this is one of worst things they have done so far, will affect cancer research and trials, the search for cures, innovation and competitiveness, our universities. Your lives.
Thanks for the shout-out, we appreciate it.
Thanks for your kind words, and your amazing contributions!
7/
This experience underscores the need for a more supportive review process to effectively promote the next generation of scientists.
We thank those reviewers and editors who were tough but fair sports, providing constructive feedback that helped improve our work. Also, we thank NIH for support.
6/
• Reviewer defamatory language 😔
• Lack of reviewer argumentation (claim, reason, support, and warrant)
• De novo concerns in 2nd round review
• Lack of support from journal team despite 8 months of costly revision experiments
5/
However, our journey wasn’t without challenges. Previous submission to a major NPG journal faced:
4/
📃 Our findings highlight critical new functions of KMT2C/KMT2D beyond transcriptional regulation, essential for understanding diseases associated with mutations in these genes.
3/
📊 Key Findings:
• Chromatin state predicts local RT in steady state and its changes during differentiation.
• H3K4me1 emerges as a top predictor.
• Loss of H3K4me1 locally impairs RT changes independent of transcription.
• H3K4me1 locally promotes replication origin activation.
2/
🔬 Approach:
• Developed an improved biotin-based DNA RT profiling method.
• Profiled 21 chromatin features by CUT&Tag during early pluripotency cell state transition.
• Used machine learning to identify chromatin features predictive of RT in steady state and during differentiation.
1/
I am grateful to have led this research, working alongside an incredible team: Liana Goehring (@lianagoehring.bsky.social), Ryan Boileau (@bffswithbiology.bsky.social), Kayla Lenshoek (@klenshoek.bsky.social), Tony Huang, and Robert Blelloch (@robertblelloch.bsky.social). 🙏
Reposted by Deniz Gökbuget
Cancer Statistics 2025 are out! #prostatecancer incidence still on the rise, mortality basically flat. Get screened so you can get treatment _when needed_. #pcsm
acsjournals.onlinelibrary.wiley.com/doi/epdf/10....